- Trials with a EudraCT protocol (8)
- Paediatric studies in scope of Art45 of the Paediatric Regulation (0)
8 result(s) found for: Perineum.
Displaying page 1 of 1.
EudraCT Number: 2006-005777-22 | Sponsor Protocol Number: MRSA-01 | Start Date*: 2009-04-07 |
Sponsor Name:Dermal Laboratories | ||
Full Title: Control of MRSA skin and wound colonisation. | ||
Medical condition: MRSA-colonised community patients with "uncomplicated" venous leg ulcers scheduled to receive regular nursing care, for 12 to 15 weeks, will be considered for the study. NB: There is no intention t... | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: GB (Prematurely Ended) | ||
Trial results: View results |
EudraCT Number: 2010-019727-55 | Sponsor Protocol Number: MRSA-2010 | Start Date*: 2010-08-17 |
Sponsor Name: | ||
Full Title: Eradikeringsbehandling av MRSA- en jämförelse av kombinerad systemisk antibiotikabehandling och lokal mupirocinbehandling med enbart mupirocin för att eradikera MRSA vid svalgbärarskap | ||
Medical condition: MRSA-bärarskap | ||
Disease: | ||
Population Age: Children, Adolescents, Under 18, Adults, Elderly | Gender: Male, Female | |
Trial protocol: SE (Completed) | ||
Trial results: (No results available) |
EudraCT Number: 2010-019254-40 | Sponsor Protocol Number: C10-109-02 | Start Date*: 2010-11-02 | |||||||||||
Sponsor Name:Lytix Biopharma AS | |||||||||||||
Full Title: A randomised, double-blind, placebo-controlled, ascending dose Phase I/IIa study to evaluate the safety, tolerability and efficacy of topical LTX-109 in subjects nasally colonized with methicillin-... | |||||||||||||
Medical condition: Nasal decolonization of MRSA/MSSA | |||||||||||||
|
|||||||||||||
Population Age: Adolescents, Under 18, Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: SE (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2019-001337-13 | Sponsor Protocol Number: 2019-01 | Start Date*: 2020-03-18 |
Sponsor Name:GETAID | ||
Full Title: USTekinumab in fistulising Perianal Crohn’s Disease: The USTAP CD study | ||
Medical condition: patient with moderate to severe Crohn’s disease with at least one active perianal fistula track | ||
Disease: | ||
Population Age: Adults | Gender: Male, Female | |
Trial protocol: FR (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2016-001528-69 | Sponsor Protocol Number: EmergencyMedicineTrial001 | Start Date*: 2016-10-07 |
Sponsor Name:Royal College of Surgeons in Ireland | ||
Full Title: PENICILLIN FOR THE EMERGENCY DEPARTMENT-DIRECTED OUTPATIENT TREATMENT OF CELLULITIS (PEDOCELL) STUDY: A NON-INFERIORITY ADAPTIVE RANDOMISED CONTROLLED TRIAL. | ||
Medical condition: Skin Infection | ||
Disease: | ||
Population Age: Adolescents, Under 18, Adults, Elderly | Gender: Male, Female | |
Trial protocol: IE (Prematurely Ended) | ||
Trial results: View results |
EudraCT Number: 2014-001013-81 | Sponsor Protocol Number: ProBaBle | Start Date*: 2014-10-10 | |||||||||||
Sponsor Name:Centro Hospitalar de São João, EPE | |||||||||||||
Full Title: Treatment of Bladder Pain Syndrome with Onabotulinum toxin A | |||||||||||||
Medical condition: Bladder Pain Syndrome | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Female | ||||||||||||
Trial protocol: PT (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2018-001125-15 | Sponsor Protocol Number: ATB-202 | Start Date*: 2018-07-16 | |||||||||||||||||||||
Sponsor Name:Atox Bio | |||||||||||||||||||||||
Full Title: Phase III, randomized, double-blind, placebo controlled, parallel-group, study of AB103 as compared to placebo in patients with necrotizing soft tissue infections (NSTI) | |||||||||||||||||||||||
Medical condition: Necrosis of soft tissue infections (NSTI) | |||||||||||||||||||||||
|
|||||||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||||||||||||
Trial protocol: FR (Completed) | |||||||||||||||||||||||
Trial results: View results |
EudraCT Number: 2021-003037-11 | Sponsor Protocol Number: 21839 | Start Date*: 2022-04-13 | |||||||||||
Sponsor Name:Bayer AG | |||||||||||||
Full Title: A parallel-group treatment, Phase 2, double-blind, three-arm study to assess efficacy and safety of finerenone plus empagliflozin compared with either finerenone or empagliflozin in participants wi... | |||||||||||||
Medical condition: Chronic kidney disease in type 2 diabetes mellitus | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: ES (Ongoing) IT (Ongoing) NL (Ongoing) DK (Ongoing) | |||||||||||||
Trial results: (No results available) |
Subscribe to this Search
To subscribe to the RSS feed for this search click here . This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
To subscribe to the RSS feed for this search click here . This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
Download Options: | |
---|---|
Number of Trials to download: | |
Download Content: | |
Download Format: | |
Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial. |
Query did not match any studies.